Report Summarizes Type 2 Diabetes Study Findings from Andhra Pradesh (Effect of Rosuvastatin on Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Prospective Interventional Study).

A new report discusses research findings on type 2 diabetes and the effect of rosuvastatin, a statin medication, on oxidative stress in patients with type 2 diabetes mellitus (T2DM). The study was conducted in Andhra Pradesh, India, and involved 24 patients with T2DM who were administered rosuvastatin tablets for 12 weeks. The results showed that rosuvastatin had a lipid-lowering effect and increased antioxidant markers, while decreasing oxidant markers. The researchers concluded that rosuvastatin could have a beneficial effect on cardiovascular risk in patients with T2DM by reducing oxidative stress and LDL-C levels. [Extracted from the article]

Copyright of Diabetes Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)